|
|
|
|
||
Re: We are excited to present the latest data from our RGLS4326 program for the treatment of ADPKD," commented Jay Hagan, President and Chief Executive Officer of Regulus. "This year's conference is an opportune occasion to share with the PKD community ou Let's hope the excitement is justified. ;<) |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
717 | Re: We are excited to present the latest data from our RGLS4326 program for the treatment of ADPKD," commented Jay Hagan, President and Chief Executive Officer of Regulus. "This year's conference is an opportune occasion to share with the PKD community ou | Southerncross1 | 0 | 6/21/2021 7:10:22 PM |